---
title: "DUNCAN CHARLES CLIFF — Ownership Dossier"
canonical: https://whiteintel.dev/entity/ea552dae-5597-5cf1-ae96-1722b40aa07e
json: https://whiteintel.dev/api/public/dossier/ea552dae-5597-5cf1-ae96-1722b40aa07e
identifier: sec:0002130896
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# DUNCAN CHARLES CLIFF

**Type:** Company  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0002130896`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/ea552dae-5597-5cf1-ae96-1722b40aa07e  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/ea552dae-5597-5cf1-ae96-1722b40aa07e  

## Ownership & control

### Holdings / subsidiaries

- **Vanda Pharmaceuticals Inc.** (director) — https://whiteintel.dev/entity/fd0a99e9-8a40-5e51-b104-33af8fce8d8a

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **DUNCAN CHARLES CLIFF**. Human view: https://whiteintel.dev/entity/ea552dae-5597-5cf1-ae96-1722b40aa07e · Structured JSON: https://whiteintel.dev/api/public/dossier/ea552dae-5597-5cf1-ae96-1722b40aa07e._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._